Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel

IF 2.1 4区医学 Q3 PSYCHIATRY

Early Intervention in Psychiatry Pub Date : 2024-05-21 DOI:10.1111/eip.13547

Katherine Camfield, Anthony Reedy, Chelsea Wolf, Alia Al-Tayyib, Deborah Rinehart, Scott A. Simpson, for the BEAT Meth MIPD Expert Panel

{"title":"Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel","authors":"Katherine Camfield, Anthony Reedy, Chelsea Wolf, Alia Al-Tayyib, Deborah Rinehart, Scott A. Simpson, for the BEAT Meth MIPD Expert Panel","doi":"10.1111/eip.13547","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>We define criteria for methamphetamine-induced psychotic disorder (MIPD) to aid in accurate and reliable diagnosis.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>An expert panel was recruited and engaged in an iterative consensus process. A literature search supported this work. The a priori level for consensus was considered ≥80% of voting panellists.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The final expert panel included 22 physicians from different backgrounds and practice environments. The panel produced two consensus diagnoses: (1) acute MIPD and (2) persisting MIPD, which is further separated into subacute and chronic timeframes. Although certain characteristics differentiate methamphetamine-induced psychosis shortly after use, identification of persisting MIPD depends largely on a history of symptom onset. All respondents voted in the final round, and both criteria were fully endorsed by 91% (20/22) of respondents. Panellists further recommended next steps in validation and research on this topic.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>These diagnostic criteria aid clinicians in differentiating methamphetamine-induced psychotic symptoms from psychosis because of other psychiatric disorders and can guide future studies. Future research might examine these criteria's prognostic significance, interrater reliability and acceptability including among persons in recovery. This work is a necessary and vital step in advancing the science of methamphetamine addiction treatment.</p>\n </section>\n </div>","PeriodicalId":11385,"journal":{"name":"Early Intervention in Psychiatry","volume":"18 12","pages":"1015-1021"},"PeriodicalIF":2.1000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Early Intervention in Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/eip.13547","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

We define criteria for methamphetamine-induced psychotic disorder (MIPD) to aid in accurate and reliable diagnosis.

Method

An expert panel was recruited and engaged in an iterative consensus process. A literature search supported this work. The a priori level for consensus was considered ≥80% of voting panellists.

Results

The final expert panel included 22 physicians from different backgrounds and practice environments. The panel produced two consensus diagnoses: (1) acute MIPD and (2) persisting MIPD, which is further separated into subacute and chronic timeframes. Although certain characteristics differentiate methamphetamine-induced psychosis shortly after use, identification of persisting MIPD depends largely on a history of symptom onset. All respondents voted in the final round, and both criteria were fully endorsed by 91% (20/22) of respondents. Panellists further recommended next steps in validation and research on this topic.

Conclusion

These diagnostic criteria aid clinicians in differentiating methamphetamine-induced psychotic symptoms from psychosis because of other psychiatric disorders and can guide future studies. Future research might examine these criteria's prognostic significance, interrater reliability and acceptability including among persons in recovery. This work is a necessary and vital step in advancing the science of methamphetamine addiction treatment.

查看原文本刊更多论文

甲基苯丙胺所致精神障碍的诊断：专家共识小组的结论。

目的：我们定义了甲基苯丙胺所致精神障碍（MIPD）的标准，以帮助进行准确可靠的诊断：方法：我们招募了一个专家小组，该小组参与了反复达成共识的过程。文献检索为这项工作提供了支持。达成共识的先验水平被认为≥80%的投票小组成员：最终的专家小组包括 22 名来自不同背景和执业环境的医生。专家组达成了两项共识诊断：（1）急性 MIPD 和（2）持续性 MIPD，后者又分为亚急性和慢性两种。虽然甲基苯丙胺诱发的精神病在使用后不久就会出现某些特征，但持续性甲基苯丙胺诱发精神病的鉴别主要取决于症状发作史。所有受访者都参加了最后一轮投票，91%（20/22）的受访者完全赞同这两项标准。小组成员还建议下一步对这一主题进行验证和研究：这些诊断标准有助于临床医生将甲基苯丙胺诱发的精神病症状与其他精神疾病引起的精神病区分开来，并能为今后的研究提供指导。未来的研究可能会对这些标准的预后意义、相互之间的可靠性和可接受性（包括康复者）进行研究。这项工作是推动甲基苯丙胺成瘾治疗科学发展的必要且重要的一步。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Early Intervention in Psychiatry 医学-精神病学

CiteScore

4.80

自引率

5.00%

发文量

112

审稿时长

6-12 weeks

期刊介绍： Early Intervention in Psychiatry publishes original research articles and reviews dealing with the early recognition, diagnosis and treatment across the full range of mental and substance use disorders, as well as the underlying epidemiological, biological, psychological and social mechanisms that influence the onset and early course of these disorders. The journal provides comprehensive coverage of early intervention for the full range of psychiatric disorders and mental health problems, including schizophrenia and other psychoses, mood and anxiety disorders, substance use disorders, eating disorders and personality disorders. Papers in any of the following fields are considered: diagnostic issues, psychopathology, clinical epidemiology, biological mechanisms, treatments and other forms of intervention, clinical trials, health services and economic research and mental health policy. Special features are also published, including hypotheses, controversies and snapshots of innovative service models.